INTEGRA Biosciences reported a successful financial year in 2025, despite exceptional economic and geopolitical challenges. When adjusted for currency effects, the company achieved a solid growth ...
Acurx Pharmaceuticals, Inc. ACXP shares are down during early trading on Friday following the company’s recent financial update, which revealed a net loss for the fourth quarter. The company reported ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果